Literature DB >> 21484793

Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program.

Murat Gök1, Folkert J van Kemenade, Daniëlle A M Heideman, Johannes Berkhof, Lawrence Rozendaal, Johan W M Spruyt, Jeroen A M Beliën, Milena Babovic, Peter J F Snijders, Chris J L M Meijer.   

Abstract

We evaluated the effect of offering brush-based vaginal self-sampling for high-risk human papillomavirus (hrHPV) testing to non-attendees of the cervical screening program on response rate, compliance to follow-up and cervical intraepithelial neoplasia grade 2 or 3 (CIN2+/CIN3+) yield. In addition, concordance of hrHPV test results between physician-taken cervical scrapes and vaginal self-samples was determined. A total of 26,409 nonattending women were randomly assigned to receive a vaginal brush device for hrHPV testing by Hybrid Capture-2 method (i.e., self-sampling group, n = 26,145) or a reinvitation for regular cytology-based screening (i.e., recall control group, n = 264). hrHPV-positive self-sampling responders were invited for a physician-taken scrape for cytology and blinded hrHPV testing. If cytology was abnormal, women were referred for colposcopy. Response rate in the self-sampling group was significantly increased compared to the recall control group (30.8% versus 6.5%; p < 0.001). The concordance rate between hrHPV detection in self-samples and corresponding physician-taken cervical scrape samples was 68.8%. Amongst women with CIN3+ and CIN2+, the concordance rates in hrHPV positivity between both samples were 95.5% and 93.8%, respectively. Adherence at baseline to cytology triage of hrHPV-positive self-sampling women (89.1%) and colposcopy referral of those with abnormal cytology (95.8%) was high. The CIN2+/CIN3+/carcinoma yields were 1.5%, 1.0% and 0.1%, respectively, in self-sampling responders. In conclusion, offering hrHPV testing on self-sampled vaginal material with a brush device to non-attendees significantly increases the attendance to the regular screening program, yields hrHPV test results that are in very good concordance with those of physician-taken scrapes in women with CIN2+/CIN3+, and is effective in detecting CIN2+/CIN3+.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21484793     DOI: 10.1002/ijc.26128

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  41 in total

1.  Home Self-Collection by Mail to Test for Human Papillomavirus and Sexually Transmitted Infections.

Authors:  Andrea C Des Marais; Yuqian Zhao; Marcia M Hobbs; Vijay Sivaraman; Lynn Barclay; Noel T Brewer; Jennifer S Smith
Journal:  Obstet Gynecol       Date:  2018-12       Impact factor: 7.661

Review 2.  Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.

Authors:  Tina R Madzima; Mandana Vahabi; Aisha Lofters
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

3.  Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.

Authors:  A T Hesselink; J Berkhof; M L van der Salm; A P van Splunter; T H Geelen; F J van Kemenade; M G B Bleeker; D A M Heideman
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

4.  Cost-effectiveness studies of HPV self-sampling: A systematic review.

Authors:  Colin Malone; Ruanne V Barnabas; Diana S M Buist; Jasmin A Tiro; Rachel L Winer
Journal:  Prev Med       Date:  2020-01-03       Impact factor: 4.018

5.  Feasibility of Cervical Cancer Screening Utilizing Self-sample Human Papillomavirus Testing Among Mexican Immigrant Women in Harris County, Texas: A Pilot Study.

Authors:  Jane R Montealegre; Patricia D Mullen; Maria L Jibaja-Weiss; Maria M Vargas Mendez; Michael E Scheurer
Journal:  J Immigr Minor Health       Date:  2015-06

6.  Comparative performance of human papillomavirus DNA testing using novel sample collection methods.

Authors:  Julia C Gage; Edward E Partridge; Alfio Rausa; Patti E Gravitt; Sholom Wacholder; Mark Schiffman; Isabel Scarinci; Philip E Castle
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

7.  Acceptability and ease of use of mailed HPV self-collection among infrequently screened women in North Carolina.

Authors:  Chelsea Anderson; Lindsay Breithaupt; Andrea Des Marais; Charlotte Rastas; Alice Richman; Lynn Barclay; Noel T Brewer; Jennifer S Smith
Journal:  Sex Transm Infect       Date:  2017-09-02       Impact factor: 3.519

8.  Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.

Authors:  Rachel L Winer; Jasmin A Tiro; Diana L Miglioretti; Chris Thayer; Tara Beatty; John Lin; Hongyuan Gao; Kilian Kimbel; Diana S M Buist
Journal:  Contemp Clin Trials       Date:  2017-11-04       Impact factor: 2.226

9.  Women's Attitudes Toward Cervicovaginal Self-Sampling for High-Risk HPV Infection on the US-Mexico Border.

Authors:  Eribeth Penaranda; Jennifer Molokwu; Silvia Flores; Theresa Byrd; Louis Brown; Navkiran Shokar
Journal:  J Low Genit Tract Dis       Date:  2015-10       Impact factor: 1.925

10.  Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.

Authors:  Wina Verlaat; Barbara C Snoek; Daniëlle A M Heideman; Saskia M Wilting; Peter J F Snijders; Putri W Novianti; Annina P van Splunter; Carel F W Peeters; Nienke E van Trommel; Leon F A G Massuger; Ruud L M Bekkers; Willem J G Melchers; Folkert J van Kemenade; Johannes Berkhof; Mark A van de Wiel; Chris J L M Meijer; Renske D M Steenbergen
Journal:  Clin Cancer Res       Date:  2018-04-09       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.